XENETIC BIOSCIENCES, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+13.6% +$157K
$-1M
Free Cash Flow↑+13.6% +$157K
$-1M
Investing Cash Flow
—
Financing Cash Flow
$4M
Capex
—
Stock-Based Comp↓-44.2% -$11K
$14K
Debt Issued
—
Debt Repaid
—
D&A
—
SBC Allocated Expense↓-100.0% -$53K
$0